Migdal Insurance & Financial Holdings Ltd.
InsurancePosition in AZN — Astrazeneca PLC
CIK 1415912
Petach Tikva, L3
Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$128,183,120
+$71,778,200 QoQ
Shares Held
676,000
+136.4% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#113
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Migdal Insurance & Financial Holdings Ltd. holds $442,034,203 across 9 Drug Manufacturers - General names. AZN ranks #2 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
562,561 | $141,562,850 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
676,000 | $128,183,120 | |
| 3 | MRK |
Merck & Co., Inc.
|
730,035 | $93,809,497 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
604,000 | $76,309,360 | |
| 5 | LLY |
ELI LILLY & Co
|
1,328 | $1,592,843 | |
| 6 | JNJ |
Johnson & Johnson
|
1,580 | $401,272 | |
| 7 | NVO |
Novo Nordisk A S
|
2,780 | $133,273 | |
| 8 | SNY |
Sanofi
|
521 | $22,225 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,183,120 | 676,000 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $56,404,920 | 286,000 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||